Rare Disease ReportAbeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten …GlobeNewswire (press release)NEW YORK and CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (… Continue reading
|
Ziopharm’s Sleeping Beauty system generates CAR–T cells in less than two days; shares up 8% premarket
Seeking Alpha Ziopharm Oncology (NASDAQ:ZIOP) announces potential point-of-care (POC) manufacturing of CAR–T cells using its Sleeping Beauty system. The preclinical data were presented at the Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond in … Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular …GlobeNewswire (press release) |
The Register |
The Register Lecture: AI turning on us? Let’s talk existential risk
The Register So, to understand how we can reap the benefits of AI, automation, synthetic biology and advanced gene-editing techniques, and so on, without, well, imperilling our very existence, we need to find a way of understanding, communicating and minimizing … |